|
Market Closed -
Other stock markets
|
Pre-market 14:44:13 | |||
| 37.37 USD | -6.60% |
|
37.81 | +1.18% |
| 08-03 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-03 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
| Market Cap | 4.56B 3.96B 3.7B 3.39B 6.4B 434B 6.51B 43.59B 17.07B 217B 17.11B 16.74B 714B | P/E 2026 * |
9.89x | P/E 2027 * | 9.68x |
|---|---|---|---|---|---|
| Enterprise Value | 4.61B 4.01B 3.74B 3.43B 6.48B 439B 6.59B 44.11B 17.28B 219B 17.32B 16.94B 723B | EV / Sales 2026 * |
3.52x | EV / Sales 2027 * | 3.13x |
| Free-Float |
97.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -6.60% | ||
| 1 week | -6.65% | ||
| Current month | -6.60% | ||
| 1 month | -6.11% | ||
| 3 months | -0.77% | ||
| 6 months | +5.42% | ||
| Current year | +4.15% |
| 1 week | 36.7 |  | 41.65 |
| 1 month | 36.7 | | 41.84 |
| Current year | 27.68 | | 42.81 |
| 1 year | 21.16 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/10/26 A | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 5/13/26 A | Free | Director | 6,518 | 0.0053% | ||
| 2/10/26 A | Free | Executive/Senior Manager | 31,380 | 0.0251% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.60% | -6.65% | +77.53% | +66.76% | 4.56B | |
| -2.39% | -6.36% | +47.10% | +149.66% | 1T | |
| -0.76% | -4.34% | +52.04% | +49.09% | 613B | |
| -2.33% | -4.60% | +25.55% | +64.44% | 433B | |
| +0.97% | -2.15% | +41.18% | +35.82% | 350B | |
| +0.88% | -3.37% | +33.22% | +41.46% | 292B | |
| +1.90% | -9.37% | +5.32% | +7.50% | 239B | |
| +2.23% | -7.72% | -1.12% | -41.69% | 206B | |
| -1.63% | +0.69% | +27.62% | +64.23% | 204B | |
| +0.72% | +0.48% | +15.88% | +73.64% | 163B | |
| Average | -0.23% | -4.16% | +32.43% | +51.09% | 350.5B | |
| Weighted average by Cap. | +0.38% | -4.34% | +35.32% | +71.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.31B 1.14B 1.06B 977M 1.84B 125B 1.87B 12.54B 4.91B 62.32B 4.92B 4.82B 206B | 1.33B 1.15B 1.08B 989M 1.86B 127B 1.9B 12.7B 4.97B 63.1B 4.99B 4.88B 208B |
| Net income | 474M 412M 384M 353M 665M 45.15B 677M 4.53B 1.78B 22.52B 1.78B 1.74B 74.27B | 487M 423M 395M 363M 684M 46.43B 696M 4.66B 1.83B 23.15B 1.83B 1.79B 76.36B |
| Net Debt | 54.5M 47.37M 44.22M 40.6M 76.55M 5.19B 77.88M 521M 204M 2.59B 205M 200M 8.54B | -403M -351M -327M -300M -567M -38.45B -576M -3.86B -1.51B -19.17B -1.52B -1.48B -63.24B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | $37.37 | -6.60% | 6,683,681 |
| 31/07/26 | $40.01 | -0.52% | 1,351,833 |
| 30/07/26 | $40.22 | +0.30% | 1,580,952 |
| 29/07/26 | $40.10 | -2.17% | 1,496,235 |
| 28/07/26 | $40.99 | +2.40% | 1,778,428 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
